Healthcare provider profile · identity verified

Anthony Scott Jordan, MD

Family Practice · BOISE, ID · NPI 1144212549

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	248	66
Atorvastatin Calcium	Atorvastatin Calcium	214	68
Metformin Hcl Er	Metformin Hcl	136	34
Lisinopril	Lisinopril	129	36
Losartan Potassium	Losartan Potassium	129	37
Omeprazole	Omeprazole	123	37
Amlodipine Besylate	Amlodipine Besylate	119	38
Metoprolol Succinate	Metoprolol Succinate	99	27
Alprazolam	Alprazolam	90	23
Simvastatin	Simvastatin	87	20
Tamsulosin Hcl	Tamsulosin Hcl	67	22
Trazodone Hcl	Trazodone Hcl	66	17
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	65	14
Gabapentin	Gabapentin	62	14
Metformin Hcl	Metformin Hcl	60	17
Pregabalin	Pregabalin	60	suppressed
Allopurinol	Allopurinol	57	15
Sertraline Hcl	Sertraline Hcl	53	15
Zolpidem Tartrate	Zolpidem Tartrate	49	14
Hydrochlorothiazide	Hydrochlorothiazide	48	14
Alendronate Sodium	Alendronate Sodium	47	15
Albuterol Sulfate Hfa	Albuterol Sulfate	45	27
Eliquis	Apixaban	44	14
Ozempic	Semaglutide	39	suppressed
Tramadol Hcl	Tramadol Hcl	38	suppressed
Lorazepam	Lorazepam	37	suppressed
Montelukast Sodium	Montelukast Sodium	34	11
Mounjaro	Tirzepatide	34	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	34	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	32	11
Duloxetine Hcl	Duloxetine Hcl	29	suppressed
Glipizide Er	Glipizide	29	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	29	suppressed
Lovastatin	Lovastatin	28	suppressed
Azelastine Hcl	Azelastine Hcl	27	suppressed
Diazepam	Diazepam	26	suppressed
Prednisone	Prednisone	26	21
Azithromycin	Azithromycin	25	19
Metoprolol Tartrate	Metoprolol Tartrate	24	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	23	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	23	suppressed
Citalopram Hbr	Citalopram Hydrobromide	22	suppressed
Irbesartan	Irbesartan	22	suppressed
Fluticasone Propionate	Fluticasone Propionate	21	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	21	suppressed
Tizanidine Hcl	Tizanidine Hcl	20	suppressed
Atenolol	Atenolol	19	suppressed
Bupropion Xl	Bupropion Hcl	19	suppressed
Estradiol	Estradiol	19	suppressed
Jardiance	Empagliflozin	19	suppressed
Promethazine Hcl	Promethazine Hcl	19	suppressed
Temazepam	Temazepam	19	suppressed
Benazepril Hcl	Benazepril Hcl	18	suppressed
Spironolactone	Spironolactone	18	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	15
Escitalopram Oxalate	Escitalopram Oxalate	17	suppressed
Meloxicam	Meloxicam	17	suppressed
Pravastatin Sodium	Pravastatin Sodium	17	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	17	15
Valsartan	Valsartan	17	suppressed
Ibuprofen	Ibuprofen	16	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	15	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	15	suppressed
Ezetimibe	Ezetimibe	15	suppressed
Furosemide	Furosemide	15	suppressed
Testosterone Cypionate	Testosterone Cypionate	15	suppressed
Topiramate	Topiramate	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Butalb-Acetaminoph-Caff-Codein	Butalbit/Acetamin/Caff/Codeine	14	suppressed
Carvedilol	Carvedilol	14	suppressed
Clopidogrel	Clopidogrel Bisulfate	14	suppressed
Belsomra	Suvorexant	13	suppressed
Donepezil Hcl	Donepezil Hcl	13	suppressed
Liothyronine Sodium	Liothyronine Sodium	13	suppressed
Oxycodone Hcl	Oxycodone Hcl	13	suppressed
Oxycontin	Oxycodone Hcl	13	suppressed
Glipizide	Glipizide	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Synthroid	Levothyroxine Sodium	12	suppressed
Diclofenac Sodium	Diclofenac Sodium	11	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error